Latest Breaking News On - பயோடெக் ப்ரைவேட் வரையறுக்கப்பட்டவை - Page 1 : comparemela.com

The Subject Expert Committee (SEC) of the Indian drug regulator, tasked with vetting Covid-19 vaccine proposals, sought additional data on Russian Covid-19 vaccine Sputnik V , while deciding on its emergency use authorisation, a senior government official said on Thursday. In September 2020, Dr. Reddy s had partnered with the Russian Direct Investment Fund (RDIF) to conduct the clinical trials of Sputnik V and for its distribution rights in India. The company had conducted Phase 2 trials in India with 1,500 participants. Phase three trials are underway. The Hyderabad-based pharma major had applied for its emergency licensure on February 19. The Committee looked into Dr. Reddy s application, on Thursday. Sputnik V has not received the emergency use authorisation yet, as the SEC has sought additional data, according to top sources.

Andhra pradeshStelis biopharmaVirchow biotech privateExpert committeeGland pharma privateRussian direct investment fundSubject expert committeeBiotech private limitedGland pharma private limitedMedical researchCovid 19 vaccinesClinical trialsHealth sciencesCovid 19 vaccineSputnikv covid 19 vaccineJohnson amp covid 19 vaccine